Alto Neuroscience (ANRO) Gains from Investment Securities (2023 - 2025)
Alto Neuroscience (ANRO) reported Gains from Investment Securities of $41000.0 for Q1 2025, down 83.13% on a YoY basis from $243000.0 in Q1 2024, and down 24.07% sequentially from $54000.0 in Q4 2024.
Alto Neuroscience (ANRO) Gains from Investment Securities (2023 - 2025) Analysis & Trends
Alto Neuroscience (ANRO) has 3 years of Gains from Investment Securities data on file, last reported at $41000.0 in Q1 2025.
- For the quarter ending Q1 2025, Gains from Investment Securities fell 83.13% year-over-year to $41000.0; the trailing twelve-month figure through Mar 2025 stood at $95000.0 (up 135.06% YoY), and the FY2024 full-year result was $297000.0, up 156.57% from the prior year.
- Gains from Investment Securities fell to $41000.0 in Q1 2025, from $54000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $243000.0 in Q1 2024 to a low of -$226000.0 in Q3 2023.
- A 3-year average of -$26714.3 and a median of -$11000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities jumped 2309.09% in 2024 and slumped 83.13% in 2025, its largest moves.
- Tracing ANRO's Gains from Investment Securities over 3 years: stood at -$166000.0 in 2023, then soared by 132.53% to $54000.0 in 2024, then declined by 24.07% to $41000.0 in 2025.
- Business Quant data shows ANRO's Gains from Investment Securities at $41000.0 in Q1 2025, $54000.0 in Q4 2024, and $243000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Mar 31, 2024 | 243,000.00 |
| Dec 31, 2023 | -166,000.00 |
| Dec 31, 2023 | -166,000.00 |
| Sep 30, 2023 | -226,000.00 |
| Sep 30, 2023 | -226,000.00 |
| Jun 30, 2023 | -122,000.00 |
| Jun 30, 2023 | -122,000.00 |
| Mar 31, 2023 | -11,000.00 |
| Mar 31, 2023 | -11,000.00 |